Bakker estimates that hundreds of compounds left on big pharma’s shelves could become much-needed drugs, but she acknowledges ...

The tariff is a reduction from the 25% levy that US president Donald J. Trump had threatened to impose on Japan if the ...

Fluorescent nanoparticles used to image a tumor near a mouse’s hind legs (circled, left) can accumulate in off-target organs, ...

Eastman to recast plastics recycling plant, Bayer to launch new herbicide, Trump pressures drug companies to reduce prices, ...

AstraZeneca has elected not to move forward with a COVID-19 preventive in the US, despite approvals in other parts of the ...

Companies that broker and facilitate scientific fraud are large, resilient, and growing rapidly, according to a new study.

The journal cites experimental error as the reason for the decision, which comes nearly 15 years after the paper’s ...

We may be on the cusp of a new era of biochemical discovery, but turning these advancements into drugs isn’t so easy ...

After years of discussions, 107 nations agree to establish the Intergovernmental Science-Policy Panel on Chemicals, Waste and Pollution ...

As the world gets wetter, studying a water cycle in flux is a major challenge. ‘You cannot bring a cloud into a laboratory,’ ...

F or a chemistry undergraduate focused on synthesis, pivoting to a PhD in physics is a bold move. But that’s exactly what Sascha Feldmann did—unlocking a research career that fuses materials ...

Gutting the National Climate Assessment is just one way the Trump administration is undermining the legal justification to limit greenhouse gas emissions ...